Long-Term NIV in COPD – Who and When?

Chairpeople:

Peter Wijkstra,¹ Wolfram Windisch²

Speakers:

Thomas Köhnlein,³ Christine Cheval⁴

1. Department of Pulmonary Diseases, University Medical Center Groningen, Groningen, Netherlands
2. Cologne-Merheim Medical Center, Cologne, Germany
3. Klinikum St. Georg gGmbH, Leipzig, Germany
4. Hôpital San Salvador, Hyères, France
5. AO Sant’Orsola Malpighi, DIMES, University of Bologna, Bologna, Italy
6. Lane Fox Respiratory Unit, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
7. HP2, INSERM U1042, Université Grenoble Alpes, Grenoble, France
8. EFCR Laboratory, Thorax and Vessels Division, Grenoble University Hospital, Grenoble, France

Disclosure:

Peter Wijkstra has received open research grants for his hospital and personal speaking fees from companies dealing with mechanical ventilation, Respironic/Philips, ResMed, VIVISOL, Emdamed, Mediq Tefa, and Air Liquide. Wolfram Windisch has received open research grants for his hospital and personal speaking fees from companies dealing with mechanical ventilation. Thomas Köhnlein has received grants and lecture fees from Deutsche Lungenstiftung, ResMed, Tyco, Weinmann, and Heinen und Löwenstein. Christine Cheval has no competing interests to disclose. Stefano Nava has no competing interests to disclose. Nick Hart has received grants and lecture fees from ResMed, Philips, and Fisher & Paykel. Jean-Louis Pépin has received personal fees from ResMed, Philips, and Fisher & Paykel for lectures during congress symposia, and unrestricted grants from ResMed, Philips, and AGIRadom for conducting clinical studies.

Acknowledgements:

Writing assistance was provided by Dr Tom Priddle, ApotheCom.

Support:

Medical writing assistance was funded by ResMed. The views and opinions expressed are those of the authors as expressed during the symposium and not necessarily those of ResMed.

Citation:

EMJ Resp. 2015;3[2]:71-77. DOI/10.33590/emjrespir/10311625. https://doi.org/10.33590/emjrespir/10311625.

Keywords:

European Respiratory Society International Congress (ERS), chronic obstructive pulmonary disease

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.